A 42 year old female presents to her gynecologist with hot flashes, night sweats, disturbed sleep cycles, day-time drowsiness, and overall fatigue. Additionally, the patient cites a significant decrease in libido and sex drive within the past six months. After hearing the patient describe her symptoms, the doctor suggests that lab work should be completed. The physician also completes a full physical and medical history, paying particular attention to details that exclude hormone replacement therapy from the potential treatments. The results of the lab work reveal mildly decreased estrogen and testosterone levels. The patient and physician agree that bio-identical hormone replacement therapy is a logical next step in treatment. Using the patient’s history, lab values, and experience, the physician creates a tailored hormone dose to substantially reduce symptoms using the smallest dose necessary.

A 62 year old female has waves of post-menopausal symptoms that conventional, long term hormone replacement therapy has failed to control. The patient is concerned about the effects of long term hormone replacement therapy and discontinues conventional therapy. Following discontinuation, the patient experiences severe menopausal symptoms, including vaginal dryness and pain during intercourse. Upon consulting with a new physician, the patient learns that bio-identical hormone replacement therapy is not administered long term. Instead, the dose is carefully titrated to the lowest effective dose and delivered as symptoms reappear over time. Following a thorough history, physical examination, and lab work, the patient begins treatment with BioTE therapy. Her therapy is monitored through her symptoms and intermittent blood work. Ultimately, BioTE allows her to control her symptoms and the potential risks associated with long term conventional therapy.